2.6M XNAS Volume
XNAS 17 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| William Duke | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2025 | 950,000 | 950,000 | - | - | Stock Option (Right to Buy) | |
| William Duke | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2025 | 300,000 | 300,000 | - | - | Restricted Stock Units | |
| Jill Andersen | Chief Legal Officer, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2025 | 500,000 | 500,000 | - | - | Restricted Stock Units | |
| Jill Andersen | Chief Legal Officer, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2025 | 950,000 | 950,000 | - | - | Stock Option (Right to Buy) | |
| Robert D. Allen | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2025 | 300,000 | 300,000 | - | - | Restricted Stock Units | |
| Robert D. Allen | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2025 | 950,000 | 950,000 | - | - | Stock Option (Right to Buy) | |
| Julie Green | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2025 | 950,000 | 950,000 | - | - | Stock Option (Right to Buy) | |
| Julie Green | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2025 | 300,000 | 300,000 | - | - | Restricted Stock Units | |
| Timothy Lee | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2025 | 950,000 | 950,000 | - | - | Stock Option (Right to Buy) | |
| Timothy Lee | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2025 | 300,000 | 300,000 | - | - | Restricted Stock Units | |
| Terrance G. Mcguire | Director | Sale of securities on an exchange or to another person at price $ 0.45 per share. | 27 Dec 2024 | 103,474 | 3,066,757 | - | 0.4 | 46,098 | Common Stock |
| Terrance G. Mcguire | Director | Sale of securities on an exchange or to another person at price $ 0.48 per share. | 27 Dec 2024 | 86,545 | 3,170,231 | - | 0.5 | 41,784 | Common Stock |
| Terrance G. Mcguire | Director | Sale of securities on an exchange or to another person at price $ 0.52 per share. | 27 Dec 2024 | 83,744 | 3,256,776 | - | 0.5 | 43,647 | Common Stock |
| Terrance G. Mcguire | Director | Sale of securities on an exchange or to another person at price $ 0.42 per share. | 20 Dec 2024 | 119,805 | 3,568,274 | - | 0.4 | 50,725 | Common Stock |
| Terrance G. Mcguire | Director | Sale of securities on an exchange or to another person at price $ 0.45 per share. | 20 Dec 2024 | 75,776 | 3,492,498 | - | 0.4 | 34,076 | Common Stock |
| Terrance G. Mcguire | Director | Sale of securities on an exchange or to another person at price $ 0.54 per share. | 20 Dec 2024 | 83,817 | 3,340,520 | - | 0.5 | 45,563 | Common Stock |
| Terrance G. Mcguire | Director | Sale of securities on an exchange or to another person at price $ 0.51 per share. | 20 Dec 2024 | 68,161 | 3,424,337 | - | 0.5 | 34,503 | Common Stock |
| Terrance G. Mcguire | Director | Sale of securities on an exchange or to another person at price $ 0.47 per share. | 17 Dec 2024 | 74,764 | 3,840,146 | - | 0.5 | 35,087 | Common Stock |
| Terrance G. Mcguire | Director | Sale of securities on an exchange or to another person at price $ 0.43 per share. | 17 Dec 2024 | 152,067 | 3,688,079 | - | 0.4 | 65,951 | Common Stock |
| Terrance G. Mcguire | Director | Sale of securities on an exchange or to another person at price $ 0.48 per share. | 17 Dec 2024 | 97,410 | 3,914,910 | - | 0.5 | 46,757 | Common Stock |
| Terrance G. Mcguire | Director | Sale of securities on an exchange or to another person at price $ 0.47 per share. | 12 Dec 2024 | 65,359 | 4,012,320 | - | 0.5 | 30,510 | Common Stock |
| Terrance G. Mcguire | Director | Sale of securities on an exchange or to another person at price $ 0.58 per share. | 12 Dec 2024 | 125,000 | 4,077,679 | - | 0.6 | 72,875 | Common Stock |
| Terrance G. Mcguire | Director | Sale of securities on an exchange or to another person at price $ 0.61 per share. | 09 Dec 2024 | 150,000 | 4,538,079 | - | 0.6 | 91,560 | Common Stock |
| Terrance G. Mcguire | Director | Sale of securities on an exchange or to another person at price $ 0.59 per share. | 09 Dec 2024 | 160,400 | 4,202,679 | - | 0.6 | 94,812 | Common Stock |
| Terrance G. Mcguire | Director | Sale of securities on an exchange or to another person at price $ 0.59 per share. | 09 Dec 2024 | 175,000 | 4,363,079 | - | 0.6 | 103,005 | Common Stock |
| Timothy Lee | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 600,000 | 600,000 | - | - | Stock Option (Right to Buy) | |
| Terrance G. Mcguire | Director | Sale of securities on an exchange or to another person at price $ 1.66 per share. | 29 May 2024 | 112,381 | 4,688,079 | - | 1.7 | 186,575 | Common Stock |
| Terrance G. Mcguire | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Kevin F. Mclaughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Marc Elia | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Srishti Gupta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Tamsin Berry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Christine Lindenboom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Sara Cotter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 41,369 | 41,369 | - | - | Stock Option (Right to Buy) | |
| Julie Green | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 240,000 | 240,000 | - | - | Stock Option (Right to Buy) | |
| Schmidt Peter | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2023 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) | |
| Jeremy Gowler | COO & CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2023 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) | |
| D. Allen Robert | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2023 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) | |
| Hering David | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2023 | 950,000 | 950,000 | - | - | Stock Option (Right to Buy) | |
| Stacy Price | Chief Tech. and Manuf. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2023 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) | |
| Jill Andersen | Chief Legal Officer, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2023 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) | |
| Sara Cotter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2023 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Michael Stephen Wyzga | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Terrance G. Mcguire | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Clive A. Meanwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Tomas J. Heyman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Marc Elia | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Tamsin Berry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Christine Lindenboom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 29,589 | 29,589 | - | - | Stock Option (Right to Buy) | |
| Robert D. Allen | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Apr 2023 | 600,000 | 600,000 | - | - | Stock Option (Right to Buy) | |
| Stacy Price | Chief Tech. and Manuf. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2023 | 475,000 | 475,000 | - | - | Stock Option (Right to Buy) | |
| Jeremy Gowler | COO & CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2022 | 625,000 | 625,000 | - | - | Stock Option (Right to Buy) | |
| Rebecca Dabora | Chief Tech and Manuf Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| David Hering | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2022 | 900,000 | 900,000 | - | - | Stock Option (Right to Buy) | |
| David Hering | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2022 | 700,000 | 700,000 | - | - | Stock Option (Right to Buy) | |
| Jill Andersen | Chief Legal Officer, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2022 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Peter Schmidt | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2022 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Peter Schmidt | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2022 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Jill Andersen | Chief Legal Officer, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2022 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
| Christine Lindenboom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Oct 2022 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| David Hering | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 4.52 per share. | 01 Sep 2022 | 8,000 | 8,000 | - | 4.5 | 36,160 | Common Stock |
| Marc Elia | Director, See Footnote 5 | Purchase of securities on an exchange or from another person at price $ 4.31 per share. | 17 Aug 2022 | 1,265,549 | 8,663,799 | - | 4.3 | 5,454,516 | Common Stock |
| Marc Elia | Director, See Footnote 5 | Purchase of securities on an exchange or from another person at price $ 4.62 per share. | 17 Aug 2022 | 584,451 | 9,248,250 | - | 4.6 | 2,700,164 | Common Stock |
| Marc Elia | Director, See Footnote 5 | Purchase of securities on an exchange or from another person at price $ 4.04 per share. | 17 Aug 2022 | 1,000,000 | 7,398,250 | - | 4.0 | 4,040,000 | Common Stock |
| David Hering | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 2,000,000 | 2,000,000 | - | - | Stock Option (Right to Buy) | |
| Michael Stephen Wyzga | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Terrance G. Mcguire | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Clive A. Meanwell | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Howard Mayer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Tomas J. Heyman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Marc Elia | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Redonda Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 44,178 | 44,178 | - | - | Stock Option (Right to Buy) | |
| Tamsin Berry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Jane Pritchett Henderson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2022 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
| Tillman U. Gerngross | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2022 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
| Lynn Connolly | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2022 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
| Rebecca Dabora | Chief Tech and Manuf Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2022 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
| David Hering | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2022 | 475,000 | 475,000 | - | - | Stock Option (Right to Buy) | |
| Elham Hershberger | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2022 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
| Jill Andersen | Chief Legal Officer, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2022 | 575,000 | 575,000 | - | - | Stock Option (Right to Buy) | |
| Redonda Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 62,605 | 62,605 | - | - | Stock Option (Right to Buy) | |
| Jill Andersen | Chief Legal Officer, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2021 | 514,863 | 514,863 | - | - | Stock Option (Right to Buy) | |
| Terrance G. Mcguire | Director | 10 Aug 2021 | 55,595 | 55,595 | - | - | Common Stock | ||
| Terrance G. Mcguire | Director | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 10 Aug 2021 | 5,219 | 60,814 | - | 17 | 88,723 | Common Stock |
| Terrance G. Mcguire | Director | 10 Aug 2021 | 19,540 | 19,540 | - | - | Common Stock | ||
| Terrance G. Mcguire | Director | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 10 Aug 2021 | 1,834 | 21,374 | - | 17 | 31,178 | Common Stock |
| Terrance G. Mcguire | Director | 10 Aug 2021 | 28,520 | 28,520 | - | - | Common Stock | ||
| Terrance G. Mcguire | Director | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 10 Aug 2021 | 2,678 | 31,198 | - | 17 | 45,526 | Common Stock |
| Terrance G. Mcguire | Director | 10 Aug 2021 | 4,755,460 | 4,755,460 | - | - | Common Stock | ||
| Terrance G. Mcguire | Director | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 10 Aug 2021 | 45,000 | 4,800,460 | - | 17 | 765,000 | Common Stock |
| Terrance G. Mcguire | Director | 10 Aug 2021 | 320,160 | 320,160 | - | - | Common Stock | ||
| Terrance G. Mcguire | Director | 10 Aug 2021 | 123,574 | 0 | - | - | Series C Preferred Stock | ||
| Terrance G. Mcguire | Director | 10 Aug 2021 | 44,076 | 0 | - | - | Series B Preferred Stock | ||
| Terrance G. Mcguire | Director | 10 Aug 2021 | 850 | 0 | - | - | Series B Preferred Stock | ||
| Terrance G. Mcguire | Director | 10 Aug 2021 | 583 | 0 | - | - | Series B Preferred Stock | ||
| Terrance G. Mcguire | Director | 10 Aug 2021 | 1,658 | 0 | - | - | Series B Preferred Stock | ||
| Terrance G. Mcguire | Director | 10 Aug 2021 | 85,061 | 0 | - | - | Series B Preferred Stock | ||
| Terrance G. Mcguire | Director | 10 Aug 2021 | 875,000 | 0 | - | - | Series A Preferred Stock | ||
| Terrance G. Mcguire | Director | 10 Aug 2021 | 3,619 | 0 | - | - | Series A Preferred Stock | ||
| Terrance G. Mcguire | Director | 10 Aug 2021 | 361,850 | 0 | - | - | Series A Preferred Stock | ||
| Terrance G. Mcguire | Director | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 10 Aug 2021 | 177,500 | 497,660 | - | 17 | 3,017,500 | Common Stock |
| Terrance G. Mcguire | Director | 10 Aug 2021 | 2,852,425 | 2,852,425 | - | - | Common Stock | ||
| Terrance G. Mcguire | Director | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 10 Aug 2021 | 267,769 | 3,120,194 | - | 17 | 4,552,073 | Common Stock |
| Terrance G. Mcguire | Director | 10 Aug 2021 | 2,479 | 0 | - | - | Series A Preferred Stock | ||
| Terrance G. Mcguire | Director | 10 Aug 2021 | 64,032 | 0 | - | - | Series C Preferred | ||
| Terrance G. Mcguire | Director | 10 Aug 2021 | 32,016 | 0 | - | - | Series C Preferred Stock | ||
| Terrance G. Mcguire | Director | 10 Aug 2021 | 1,235 | 0 | - | - | Series C Preferred Stock | ||
| Terrance G. Mcguire | Director | 10 Aug 2021 | 846 | 0 | - | - | Series C Preferred Stock | ||
| Terrance G. Mcguire | Director | 10 Aug 2021 | 7,052 | 0 | - | - | Series A Preferred Stock | ||
| Terrance G. Mcguire | Director | 10 Aug 2021 | 2,409 | 0 | - | - | Series C Preferred Stock | ||
| Tillman U. Gerngross | Director, Chief Executive Officer, Ten Percent Owner | 10 Aug 2021 | 25,860,700 | 27,845,995 | - | - | Common Stock | ||
| Tillman U. Gerngross | Director, Chief Executive Officer, Ten Percent Owner | 10 Aug 2021 | 128,064 | 0 | - | - | Series C Preferred Stock | ||
| Tillman U. Gerngross | Director, Chief Executive Officer, Ten Percent Owner | 10 Aug 2021 | 44,076 | 0 | - | - | Series B Preferred Stock | ||
| Tillman U. Gerngross | Director, Chief Executive Officer, Ten Percent Owner | 10 Aug 2021 | 5,000,000 | 0 | - | - | Series A Preferred Stock | ||
| Ajay Royan | Director, Ten Percent Owner | 10 Aug 2021 | 422,612 | 0 | - | - | Series C Preferred Stock | ||
| Ajay Royan | Director, Ten Percent Owner | 10 Aug 2021 | 1,250,000 | 0 | - | - | Series A Preferred Stock | ||
| Ajay Royan | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 10 Aug 2021 | 1,997,000 | 11,241,580 | - | 17 | 33,949,000 | Common Stock |
| Ajay Royan | Director, Ten Percent Owner | 10 Aug 2021 | 9,244,580 | 9,244,580 | - | - | Common Stock | ||
| Ajay Royan | Director, Ten Percent Owner | 10 Aug 2021 | 176,304 | 0 | - | - | Series B Preferred Stock | ||
| Michael Stephen Wyzga | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2021 | 71,186 | 71,186 | - | - | Stock Option (Right to Buy) | |
| Terrance G. Mcguire | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2021 | 35,593 | 35,593 | - | - | Stock Option (Right to Buy) | |
| Howard Mayer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2021 | 35,593 | 35,593 | - | - | Stock Option (Right to Buy) | |
| Rene Russo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2021 | 35,593 | 35,593 | - | - | Stock Option (Right to Buy) | |
| Ajay Royan | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2021 | 35,593 | 35,593 | - | - | Stock Option (Right to Buy) |